Technical Analysis for YMAB - Y-mAbs Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 26.05 3.91% 0.98
YMAB closed up 3.91 percent on Friday, October 11, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical YMAB trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
NR7 Range Contraction 3.91%
Stochastic Reached Oversold Weakness 3.91%
Wide Bands Range Expansion 3.91%
Oversold Stochastic Weakness 3.91%
Spinning Top Other 4.20%
Inside Day Range Contraction 4.20%
Wide Bands Range Expansion 4.20%
Down 3 Days in a Row Weakness 4.20%
Wide Bands Range Expansion 3.62%

Older signals for YMAB ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Y-mAbs Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody therapeutic products for cancer treatment in the United States. It is developing naxitamab for the treatment of pediatric patients with relapsed or refractory, high-risk neuroblastoma, as well as other GD2 positive tumors; and omburtamab for the treatment of pediatric patients with central nervous system/leptomeningeal metastases, desmoplastic small round cell tumors, diffuse intrinsic pontine glioma, and other B7-H3 positive tumors. The company has a license and research collaboration agreement with Memorial Sloan-Kettering Cancer Center. Y-mAbs Therapeutics, Inc. was founded in 2015 and is headquartered in New York, New York.
Biopharmaceutical Cancer Cancer Treatment Brain Tumor Neuroblastoma Glioma Diffuse Intrinsic Pontine Glioma Refractory
Is YMAB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.27
52 Week Low 15.17
Average Volume 146,736
200-Day Moving Average 23.5239
50-Day Moving Average 26.7714
20-Day Moving Average 27.5125
10-Day Moving Average 25.174
Average True Range 1.5128
ADX 20.32
+DI 20.9139
-DI 21.2001
Chandelier Exit (Long, 3 ATRs ) 27.7316
Chandelier Exit (Short, 3 ATRs ) 27.9384
Upper Bollinger Band 33.0483
Lower Bollinger Band 21.9767
Percent B (%b) 0.37
BandWidth 40.242072
MACD Line -0.6916
MACD Signal Line -0.4201
MACD Histogram -0.2715
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.96
Resistance 3 (R3) 28.80 27.68 28.48
Resistance 2 (R2) 27.68 26.94 27.76 28.31
Resistance 1 (R1) 26.86 26.48 27.27 27.02 28.15
Pivot Point 25.74 25.74 25.94 25.82 25.74
Support 1 (S1) 24.92 25.00 25.33 25.08 23.95
Support 2 (S2) 23.80 24.54 23.88 23.79
Support 3 (S3) 22.98 23.80 23.63
Support 4 (S4) 23.14